D'Agostino G - Search Results

1

Aiello V, Ricci N, Palazzi P, D'Agostino G, Azzini G, Calzolari E. Aiello V, et al. Am J Med Genet. 1994 Apr 15;50(3):294-5. doi: 10.1002/ajmg.1320500314. Am J Med Genet. 1994. PMID: 8042675

2

The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation.

Lombardi D, Sacchi A, D'Agostino G, Tibursi G. Lombardi D, et al. Exp Cell Res. 1995 Apr;217(2):267-71. doi: 10.1006/excr.1995.1086. Exp Cell Res. 1995. PMID: 7698225

3

Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.

Mecchia M, Matarrese P, Malorni W, D'Agostino G, Sestili P, Santini SM, Gauzzi MC, Venditti M, Mazzocchi A, Parmiani G, Belardelli F, Ferrantini M. Mecchia M, et al. Gene Ther. 2000 Jan;7(2):167-79. doi: 10.1038/sj.gt.3301059. Gene Ther. 2000. PMID: 10673721

4

Beta 4 integrin subunit expression is downregulated in low metastatic carcinoma variants.

Cimino L, Perrotti D, D'Agostino G, Falcioni R, Sacchi A. Cimino L, et al. Cancer Detect Prev. 1997;21(2):158-66. Cancer Detect Prev. 1997. PMID: 9101077

5

Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.

Santodonato L, D'Agostino G, Santini SM, Carlei D, Musiani P, Modesti A, Signorelli P, Belardelli F, Ferrantini M. Santodonato L, et al. Gene Ther. 1997 Nov;4(11):1246-55. doi: 10.1038/sj.gt.3300518. Gene Ther. 1997. PMID: 9425449

6

Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice.

D'Agostino G, Aricò E, Santodonato L, Venditti M, Sestili P, Masuelli L, Coletti A, Modesti A, Picchio G, Mosier DE, Ferrantini M, Belardelli F. D'Agostino G, et al. J Interferon Cytokine Res. 1999 Nov;19(11):1305-16. doi: 10.1089/107999099312984. J Interferon Cytokine Res. 1999. PMID: 10574624

7

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

Santini SM, Lapenta C, Santodonato L, D'Agostino G, Belardelli F, Ferrantini M. Santini SM, et al. Handb Exp Pharmacol. 2009;(188):295-317. doi: 10.1007/978-3-540-71029-5_14. Handb Exp Pharmacol. 2009. PMID: 19031032 Review.

8

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

Santodonato L, D'Agostino G, Nisini R, Mariotti S, Monque DM, Spada M, Lattanzi L, Perrone MP, Andreotti M, Belardelli F, Ferrantini M. Santodonato L, et al. J Immunol. 2003 May 15;170(10):5195-202. doi: 10.4049/jimmunol.170.10.5195. J Immunol. 2003. PMID: 12734367

9

IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.

Lattanzi L, Rozera C, Marescotti D, D'Agostino G, Santodonato L, Cellini S, Belardelli F, Gavioli R, Ferrantini M. Lattanzi L, et al. Immunobiology. 2011 May;216(5):537-47. doi: 10.1016/j.imbio.2010.10.003. Epub 2010 Oct 21. Immunobiology. 2011. PMID: 21093097

10

MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.

Aricò E, Monque DM, D'Agostino G, Moschella F, Venditti M, Kalinke U, Allen DJ, Stewart JP, Nash AA, Belardelli F, Ferrantini M. Aricò E, et al. Vaccine. 2011 May 23;29(23):3935-44. doi: 10.1016/j.vaccine.2011.03.092. Epub 2011 Apr 8. Vaccine. 2011. PMID: 21481326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters